Company Filing History:
Years Active: 2021
Title: Hiroko Ohmiya: Innovator in Corneal Endothelial Cell Research
Introduction
Hiroko Ohmiya is a prominent inventor based in Saitama, Japan. She has made significant contributions to the field of ophthalmology, particularly in the study of corneal endothelial cells. Her innovative work has led to the development of a unique molecular marker that has the potential to advance research and treatment in this area.
Latest Patents
Hiroko Ohmiya holds a patent for a corneal endothelial cell marker. This patent describes a molecular marker that is specifically expressed in corneal endothelial cells. The invention includes methods for producing and evaluating corneal endothelial cells using this marker. The marker is based on at least one molecule selected from a group that includes ZP4, MRGPRX3, GRIP1, GLP1R, HTR1D, and CLRN1.
Career Highlights
Hiroko Ohmiya is affiliated with Osaka University, where she continues her research and development efforts. Her work has garnered attention for its potential applications in regenerative medicine and cell therapy. With her innovative approach, she is paving the way for new treatments for corneal diseases.
Collaborations
Hiroko collaborates with esteemed colleagues such as Kohji Nishida and Motokazu Tsujikawa. Their combined expertise enhances the research efforts and contributes to the advancement of knowledge in the field.
Conclusion
Hiroko Ohmiya is a trailblazer in the field of corneal endothelial cell research, with her innovative patent and collaborative efforts making a significant impact. Her work exemplifies the importance of innovation in advancing medical science and improving patient outcomes.